EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A critical assessment of matching-adjusted indirect comparisons in relation to target populations

Ziren Jiang iD, Jialing Liu, Demissie Alemayehu, Joseph C Cappelleri, Devin Abrahami, Yong Chen, Haitao Chu

Research Synthesis Methods · 2025

DOI: 10.1017/rsm.2025.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research Synthesis Methods, 2025. Verfasst von Ziren Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matching-adjusted indirect comparison (MAIC) has been increasingly applied in health technology assessments (HTA). By reweighting subjects from a trial with individual participant data (IPD) to match the summary statistics of covariates in another trial with aggregate data (AgD), MAIC enables a comparison of the interventions for the AgD trial population. However, when there are imbalances in effect modifiers with different magnitudes of modification across treatments, contradictory conclusions may arise if MAIC is performed with the IPD and AgD swapped between trials. This can lead to the “MAIC paradox,” where different entities reach opposing conclusions about which treatment is more effective, despite analyzing the same data. In this paper, we use synthetic data to illustrate this paradox and emphasize the importance of clearly defining the target population in HTA submissions. Additionally, we recommend making de-identified IPD available to HTA agencies, enabling further indirect comparisons that better reflect the overall population represented by both IPD and AgD trials, as well as other relevant target populations for policy decisions. This would help ensure more accurate and consistent assessments of comparative effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalHumansResearch DesignData Interpretation, StatisticalModels, StatisticalCost-Benefit AnalysisClinical Trials as TopicComparative Effectiveness ResearchAlgorithms

Stichwörter der Autor:innen

MAIC paradoxhealth technology assessmentindirect treatment comparisonmatching-adjusted indirect comparisonpopulation-adjusted indirect comparison

Autor:innen und Institutionen

  • School of Public Health, Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA.
  • Statistical Research and Data Science Center, Pfizer Inc., New York, NY, USA.
  • Global Access and Value, Pfizer Inc., New York, NY, USA.
  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
  • The Center for Health AI and Synthesis of Evidence (CHASE), University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Ziren Jiang

Zitieren

APA

Jiang, Z., Liu, J., Alemayehu, D., Cappelleri, J. C., Abrahami, D., Chen, Y., & Chu, H. (2025). A critical assessment of matching-adjusted indirect comparisons in relation to target populations. Research Synthesis Methods. https://doi.org/10.1017/rsm.2025.10

Vancouver

Jiang Z, Liu J, Alemayehu D, Cappelleri JC, Abrahami D, Chen Y, et al. A critical assessment of matching-adjusted indirect comparisons in relation to target populations. Research Synthesis Methods. 2025. doi:10.1017/rsm.2025.10

BibTeX
@article{Jiang2025,
  author = {Jiang, Ziren and Liu, Jialing and Alemayehu, Demissie and Cappelleri, Joseph C and Abrahami, Devin and Chen, Yong and Chu, Haitao},
  title = {A critical assessment of matching-adjusted indirect comparisons in relation to target populations},
  journal = {Research Synthesis Methods},
  year = {2025},
  doi = {10.1017/rsm.2025.10}
}
Kostenlos starten →